Glioma clinical trials in Maryland
11 studies for Glioma are looking for participants at sites in Maryland.
Cities in Maryland
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
RecruitingPhase 1/2
12 Months – 21 Years · All sexes · Updated Oct 1, 2026 · NCT05099003Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Johns Hopkins Sidney Kimmel Cancer Center - Baltimore, Baltimore
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07326566Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1/2
Ages 18 to 99 · All sexes · Updated Sep 28, 2026 · NCT07416188A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1/2
Ages 15 and older · All sexes · Updated Aug 28, 2026 · NCT05588141Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- John Hopkins University, Baltimore
RecruitingPhase 1
Ages 1 to 25 · All sexes · Updated Aug 18, 2026 · NCT04485559Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Aug 14, 2026 · NCT06344130PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1/2
Ages 18 to 120 · All sexes · Updated Aug 12, 2026 · NCT06161519A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- The John Hopkins Hospital, Baltimore
- Maryland Oncology Hematology- Columbia, Rockville
RecruitingPhase 2
Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
- Maryland Proton Treatment Center, Baltimore
- University of Maryland Greenebaum Cancer Center, Baltimore
- UCH Kaufman Cancer Center, Bel Air
- and 2 more
Recruiting
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT04699773Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
- National Institutes of Health, Bethesda
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT04541082Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas
- Rosy Njonkou Tchoquessi, Baltimore
RecruitingPhase 1
Ages 18 to 80 · All sexes · Updated Sep 22, 2025 · NCT04772456From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.